Notch signaling: a mediator of beta-cell de-differentiation in diabetes?

Martine I Darville1, Décio L Eizirik

  • 1Laboratory of Experimental Medicine, Université Libre de Bruxelles, Belgium. mdarvill@ulb.ac.be

Insights

Cytokines induce Notch signaling in pancreatic beta-cells, potentially causing dysfunction in type 1 diabetes. Notch activation inhibits differentiated functions in dividing beta-cells but not terminally differentiated ones.

Area of Science:

  • Endocrinology
  • Immunology
  • Developmental Biology

Background:

  • Cytokines mediate pancreatic beta-cell dysfunction and death in type 1 diabetes mellitus.
  • Microarray analysis reveals altered gene expression in beta-cells exposed to inflammatory cytokines, including upregulation of the Notch signaling pathway.
  • Re-expression of developmental pathways like Notch may contribute to beta-cell loss-of-function during autoimmune attack.

Purpose of the Study:

  • To investigate the role of Notch signaling in cytokine-induced pancreatic beta-cell dysfunction.
  • To determine how Notch pathway activation affects differentiated functions in beta-cells.

Main Methods:

  • Exposure of rat primary beta-cells and INS-1E cells to cytokines (interleukin-1beta + interferon-gamma).
  • Microarray analysis to assess gene expression changes.
  • Transfection with a constitutively active Notch receptor to study pathway activation.
  • Measurement of Pdx1 and insulin expression levels.

Main Results:

  • Cytokine exposure upregulated Notch receptors, ligands, and the target gene Hes1 in primary rat beta-cells.
  • Constitutively active Notch receptor activation downregulated Pdx1 and insulin expression in dividing INS-1E cells.
  • Notch activation did not affect Pdx1 and insulin expression in terminally differentiated primary rat beta-cells.

Conclusions:

  • Activation of the Notch signaling pathway is implicated in pancreatic beta-cell dysfunction.
  • Notch pathway activation inhibits differentiated functions in dividing beta-cells.
  • Terminally differentiated beta-cells are resistant to Notch-mediated inhibition of differentiated functions, suggesting a potential mechanism for beta-cell survival in type 1 diabetes.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...